Loading...
Home2019-11-26T01:52:48+00:00

THROUGH UNIVERSITY RESEARCH AND DEVELOPMENT

With teams at Western University, CanaQuest Medical Corp has created a number of patentable product formulations. Our research and product development focuses on health products and nutraceuticals utilizing cannabis and botanical oil extracts including algae oils.

To learn more about our value proposition and the benefits of our commercial-ready products, click the following link: CanaQuest Presentation.


Click picture above to see full-sized image.

Product Formulations

PRODUCT FORMULATIONS

A critical mass of clinical evidence regarding the efficacy of medical cannabis is refuting political, scientific, and other skeptics, and opening minds hardened by decades of anti-cannabis propaganda. Our goal is to develop better alternative treatments to traditional pharmaceuticals for people struggling with a variety of health challenges.

CQ1 (Mentabinol®)

Commercial ready and effective for anxiety, depression, schizophrenia, and more.

CQ2 (Coming Soon)

Effective for anxiety, PTSD (chronic stress induced), pain and addiction.

CQ3

Effective for therapies for specific mental health symptom clusters.

CQ4

Effective for mitigation of the spread of cancerous tumors.

Product Portfolio

FOCUS AREAS

Anxiety

Addiction

Depression

Schizophrenia

PTSD

Pain

Vision

OUR VISION

Our vision is to be a global leader in the formulation and development of health products from cannabis derivatives.

Company Information

IN THE NEWS

View All News
1709, 2019

CanaQuest Medical Corp announces Filing of International Cannabis Patent

September 17th, 2019|

A NOVEL BOTANICAL AND TETRAHYDROCANNABINOL (“THC”) FORMULATION FOR THE REDUCTION OF CANNABIS-INDUCED NEGATIVE NEUROPSYCHIATRIC SIDE-EFFECTS Research & development a primary focus for this medical cannabis company TORONTO – September 17, 2019 − CANAQUEST MEDICAL CORP (OTC Markets: [...]